Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review

참고문헌 (10)

1. Franchini M, "COVID-19 vaccine-associated immune thrombosis and thrombocytopenia(VITT) : diagnostic and therapeutic recommendations for a new syndrome", Eur J Haematol, 107, pp.173~180 (2021)
2. Scully M, "Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination", N Engl J Med, 384, pp.2202~2211 (2021)
3. Park JY, "Systemic adverse events and use of antipyretics predict the neutralizing antibody positivity early after the first dose of ChAdOx1 coronavirus disease vaccine", J Clin Med, 10, pp.2844~ (2021)
4. Adeboye A, "Assessment of functional pain score by comparing to traditional pain scores", Cureus, 13, pp.e16847~ (2021)
5. Terpos E, "High prevalence of anti-PF4 antibodies following ChAdOx1 nCov-19(AZD1222)vaccination even in the absence of thrombotic events", Vaccines(Basel), 9, pp.712~ (2021)
6. Thiele T, "Frequency of positive anti-PF4", polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2, 2021, pp.138, 299~303
7. Kim Jung-Ah, "Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal Study", Annals of Laboratory Medicine, 42(6), pp.688~692 (2022), 대한진단검사의학회[DOI]
8. Sørvoll IH, "An observational study to identify the prevalence of thrombocytopenia and anti-PF4", polyanion antibodies in Norwegian health care workers after COVID-19 vaccination, 2021, pp.19, 1813~1818
9. Platton S, "Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination", J Thromb Haemost, 19, pp.2007~2013 (2021)
10. Satoh T, "Heparin-dependent and-independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus", Rheumatology(Oxford), 51, pp.1721~1728 (2012)

관련 논문AI추천